Zydus Lifesciences LimitedShare price targets & analyst calls
₹1,215+11.10 (+0.92%)
As of 28 Sept 2026
Analysts lean BUY·6 of 8 long-term calls BUY·consensus 1Y target ₹1,279.63 (5.3% above CMP)
₹1,279.63
5.3% above CMP
₹1,040 – ₹1,457
8 active 1Y targets
12 open
10 BUY · 2 SELL (all horizons)
38%
15 of 40 closed calls hit
Watch ZYDUSLIFE for new buy/sell callsGet alertsSee 58 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips · page 2 of 2
BUYZYDUSLIFEZydus LifesciencesHorizon: Intraday* (horizon not stated by the source; assumed from the target's distance)Expired
+0.57% realisedNA upside left
₹1,147.5
At expiry
SL
₹1,124
Entry*
₹1,141
Target
₹1,170
expired 6 Jul 2026, 3:20 pm
MJManas Jaiswal· via CNBC Awaaz.12w ago
BUYZYDUSLIFEZydus LifesciencesHorizon: Intraday* (horizon not stated by the source; assumed from the target's distance)Expired
+1.01% realisedNA upside left
₹1,141.1
At expiry
SL
₹1,114
Entry*
₹1,129.7
Target
₹1,160
expired 3 Jul 2026, 3:20 pm
MJManas Jaiswal· via CNBC Awaaz.12w ago
Showing 51–52 of 52